Well hopefully TPIV will make up for all our mishaps. If this runs to multiple dollars I should be alright. There are some here that believe this could see as much as $10 either on its own or by a buy out.
That would be incredible but I'd hate to say I sold this at $10 and it pulled a JAZZ and went to $150. That's why I feel as though I have enough shares now where if we had a miracle and it went to $10 I would make sure I keep enough just in case it goes much higher. Of course we need this to get out of the .60's first, haha.
So easy to get ahead of yourself.
Hopefully the can hit all the milestones they have listed and grow the pipeline that they have in place. Like Glynn has said, let the data speak. Companies like JAZZ, BLUE, ADXS and CELG have taken years of trials and different studies before achieving the value they have today. The milestones they have in place are very reasonable. The possible multiple P2 studies seem to have the capital in place for now to complete them. Hopefully they can get uplisted in order to attract many institutions to buy in, and to also attract possible suitors to partner up with to help us with R&D. The DoD grant gives the science validation by a third party that found it worthy of such a generous grant.
With the approval of Orphan Status TPIV will qualify for many other grants that RK will be watching out for. We have a great bunch of knowledgeable investors on this board. Many with years of experience with this company. We also have a billionaire who is holding almost half of the OS, and he has a history of holding his shares, PPHM being one of his companies that he has been holding for quite some time. I believe we already have a great partnership with one of the leading acedemic clinics in Mayo. And lest not forget we have two brilliant doctors acting as lead principles with the TNBC P2 that has been fully funded. One of those scientist, Dr Edith Perez who has ties to Genentech which she was lead scientist on Herpicin and helped get that to market.
This is forming into a great story and we aren't even out of the first chapter yet. Let's hope it turns out to be a best seller.
Good luck, hold tight, and God Bless us all :-)
News 
Market Data 
Discover 
